找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

123456
返回列表
打印 上一主題 下一主題

Titlebook: Clinical Pharmacology: Current Topics and Case Studies; Markus Müller Book 2016Latest edition Springer International Publishing Switzerlan

[復(fù)制鏈接]
樓主: 厭倦了我
51#
發(fā)表于 2025-3-30 11:46:35 | 只看該作者
Modeling Fault Trees Using Petri Netsity will be translated into clinical practice. According to the current intriguing concepts of pharmacogenetics and pharmacogenomics, genetic information of individuals can be used to avoid “trial and error” scenarios during medication. Based on evidence from genomic testing, medicine is expected to
52#
發(fā)表于 2025-3-30 16:15:58 | 只看該作者
https://doi.org/10.1007/978-1-4471-0937-2te of infection for a sufficient amount of time that would stop the development of bacterial resistance and on the susceptibility and severity of the infection. Therapeutic success of therapy is also dependent on the physiological characteristics of the host, including disease state, age, comorbidit
53#
發(fā)表于 2025-3-30 16:37:55 | 只看該作者
Hans-Peter Meske,Wolfgang A. Halangnd consequences of diseases. The following chapter will give the reader a brief overview on how epidemiological data are gained and analyzed. Furthermore, the chapter will briefly cover the importance of biostatistics in the interpretation of study data as well as possible pitfalls.
54#
發(fā)表于 2025-3-30 22:08:16 | 只看該作者
55#
發(fā)表于 2025-3-31 04:32:07 | 只看該作者
56#
發(fā)表于 2025-3-31 08:59:56 | 只看該作者
Current Issues in Drug Developmentes, most notably infections, have extremely satisfying therapeutic success rates, and many serious diseases like diabetes mellitus or some forms of cancer have become chronic, stable diseases and do not lead to extreme shortages of life years any longer. Prime examples for success stories in drug de
57#
發(fā)表于 2025-3-31 10:43:14 | 只看該作者
Current Issues in Drug Regulationjectives: first, into an obligation to protect patients against ineffective or harmful drugs and, second, to protect patients against the consequences of untreated disease. The first objective results in a gatekeeper function and obliges regulators to apply stringent standards of assessment and to d
58#
發(fā)表于 2025-3-31 13:39:36 | 只看該作者
123456
返回列表
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-22 00:56
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
黄骅市| 大石桥市| 韶山市| 白水县| 青龙| 应用必备| 枣强县| 鹤山市| 大悟县| 卓尼县| 九江县| 修武县| 中牟县| 镇宁| 广丰县| 灵丘县| 宁陵县| 志丹县| 蚌埠市| 鹤峰县| 博野县| 巫溪县| 和硕县| 阜新市| 垦利县| 玉屏| 鄂伦春自治旗| 新泰市| 顺昌县| 高淳县| 卓资县| 大埔区| 仁布县| 临夏市| 通江县| 仁布县| 福泉市| 崇左市| 宜城市| 东乡县| 新沂市|